Introduction to Surmodics Inc.

Surmodics Inc. is a pioneering medical device company headquartered in Eden Prairie, Minnesota, specializing in surface modification technologies, drug delivery systems, and in vitro diagnostics. With a market reputation built on over 40 years of innovation, Surmodics is recognized as a top healthcare company that enables partner organizations to enhance the performance and safety of medical devices. The company’s core expertise lies in coating technologies that improve biocompatibility, lubricity, and drug elution, serving a broad spectrum of therapeutic areas including cardiovascular, neurovascular, peripheral vascular, and ophthalmology. Surmodics operates on a global scale, with manufacturing facilities in the United States and partnerships across Europe and Asia. Its clientele includes leading medical device manufacturers, pharmaceutical companies, and diagnostic labs that rely on Surmodics’ proprietary solutions to meet regulatory standards and clinical demands. As of 2025, Surmodics employs over 500 professionals, with annual revenues exceeding $120 million, and continues to expand its intellectual property portfolio with more than 900 issued and pending patents. The company is publicly traded on NASDAQ under the ticker SRDX, and its consistent performance has earned it a strong position within the healthcare innovation ecosystem. Surmodics is not merely a service provider but a strategic partner in the development of next-generation medical technologies, from drug-coated balloons to advanced diagnostic assays.

Company History and Business Evolution

Surmodics was founded in 1979 as a spin-off from the University of Minnesota, initially focusing on surface chemistry research. The company's early breakthroughs included hydrophilic coatings that dramatically reduced friction on medical catheters, leading to widespread adoption in the 1980s. Throughout the 1990s, Surmodics expanded into drug delivery coatings, particularly for coronary stents, and established itself as a key supplier to major device manufacturers. The early 2000s marked a period of rapid growth, with the launch of the Serene® drug-coated balloon platform and acquisition of Genzyme’s drug delivery business in 2007. Surmodics entered the diagnostics space in 2010 with its BioFX and SureWash assay technologies, diversifying beyond coatings. Major milestones include the FDA approval of the SurVeil™ drug-coated balloon in 2021, a proprietary product that signaled Surmodics’ transition from an enabling technology supplier to a fully integrated medical device developer. The company has also expanded through strategic acquisitions, such as the purchase of Svelte Medical Systems in 2022 to enhance its catheter delivery capabilities. Today, Surmodics operates three pillars: Medical Device Coatings, Drug Delivery (Pharma), and In Vitro Diagnostics. Its evolution reflects a commitment to solving complex biological interface challenges, and it continues to invest in R&D to address emerging needs in interventional medicine. The company’s history is marked by resilience and adaptability, navigating regulatory shifts and market demands while maintaining a strong innovation pipeline.

Surmodics Inc. at a Glance

• Headquarters: Eden Prairie, Minnesota, USA
• Founding Year: 1979
• CEO: Gary Maharaj (as of 2025)
• Revenue: $120 million (FY2024)
• Employee Count: Over 500
• Stock Ticker: SRDX (NASDAQ)
• Industry: Medical Devices & Healthcare
• Core Technologies: Hydrophilic coatings, drug-delivery coatings, diagnostic assays
• Patents: 900+ issued and pending worldwide
• Key Products: SurVeil™ DCB, Serene® DCB, SureWash™, BioFX®
• Markets Served: Cardiovascular, neurovascular, peripheral, ophthalmology
• Global Reach: Partners in over 30 countries
• Manufacturing: ISO 13485 certified facilities in Minnesota
• R&D Investment: 15% of revenue annually
• Regulatory Approvals: FDA, CE Mark, PMDA
• Awards: Minnesota Tekne Award, MedTech Innovator
• Social Responsibility: Sustainability programs, community health initiatives
• Workforce Diversity: 40% women in leadership roles
• Customer Base: Top-20 global medical device companies
• Recent Milestone: Launch of next-generation drug-coated balloon in 2024

Mission, Vision, and Core Corporate Values

Surmodics’ mission is to improve patient outcomes by enabling superior medical devices through innovative surface solutions. The vision is to be the global leader in surface modification technologies, empowering healthcare providers to deliver safer, more effective treatments. Core values include: Innovation – relentless pursuit of breakthrough technologies; Integrity – upholding highest ethical standards in all interactions; Collaboration – working closely with partners to solve complex clinical challenges; Quality – delivering products that exceed regulatory and customer expectations; and Impact – making a measurable difference in patient lives. These values guide decision-making from the laboratory to the boardroom, fostering a culture of trust and excellence. The company regularly communicates its mission through internal newsletters, town halls, and annual sustainability reports, ensuring alignment across all departments.

Business Strategy and Future Roadmap

Surmodics’ business strategy focuses on three key pillars: Technology Leadership – maintaining proprietary expertise in coatings and drug delivery; Customer Partnership – offering customized solutions through joint development agreements; and Product Commercialization – bringing owned-device products like the SurVeil DCB to market. The future roadmap includes expansion into ophthalmology and neurology, development of biodegradable coatings, and leveraging AI for coating design. Surmodics aims to double its revenue by 2030 through organic growth and strategic acquisitions, while increasing its direct device sales. Sustainability initiatives are also central, with goals to reduce carbon footprint by 30% by 2027. The company plans to invest in digital health integrations, such as smart coatings that provide real-time feedback on implant performance.

Products, Technologies, and Services

Surmodics offers a comprehensive portfolio: Medical Device Coatings – lubricious (hydrophilic) coatings, antimicrobial coatings, and drug-eluting coatings for stents, catheters, and guidewires; Drug Delivery Systems – proprietary formulations for controlled release of therapeutic agents from balloons and implants; In Vitro Diagnostics – assay development kits and surface chemistry for microplates and microfluidic devices. Flagship products include the SurVeil™ Drug-Coated Balloon for peripheral artery disease, the Serene® Drug-Coated Balloon for coronary in-stent restenosis, and the SureWash™ diagnostic reagent. Services range from toll coating and R&D consulting to regulatory support and intellectual property licensing. Surmodics’ technologies are validated by hundreds of peer-reviewed studies and are used in millions of medical procedures annually.

Industries and Markets Served

Surmodics serves the medical device industry directly, but its technologies impact multiple healthcare sectors: Cardiovascular – drug-coated balloons, stents, guide catheters; Neurovascular – microcatheters and embolic coils; Peripheral Vascular – angioplasty balloons and atherectomy devices; Ophthalmology – intraocular lenses and drug delivery implants; Diagnostics – ELISA kits, lateral flow assays, and PCR plates; Pharmaceutical – parenteral drug formulations and combination products. The company also partners with academic research institutions for early-stage development. Geographically, North America accounts for 60% of revenue, followed by Europe (25%) and Asia-Pacific (15%). Emerging markets in Latin America and the Middle East offer growth potential for drug-coated balloon adoption in underserved regions.

Leadership and Management Philosophy

Surmodics’ leadership team, led by CEO Gary Maharaj, emphasizes a philosophy of empowerment through expertise. Maharaj, who joined in 2016, previously led Boston Scientific’s surgical business and brings a patient-centered approach. The executive team includes veteran leaders in R&D, operations, and regulatory affairs. Management fosters an open-door policy, with regular “Innovation Fridays” where employees pitch ideas. The company invests in leadership development programs and metrics-based performance reviews. Ethical decision-making is reinforced through a compliance hotline and annual training. Surmodics also maintains a board of directors with diverse backgrounds in healthcare, finance, and technology.

Corporate Events, Conferences, and Community Engagement

Surmodics actively participates in major medical conferences such as TCT (Transcatheter Cardiovascular Therapeutics), EuroPCR, and the Cardiovascular Research Technologies (CRT) meeting. The company hosts annual user group meetings for coating partners and diagnostic customers. Community engagement includes sponsorship of STEM education programs in the Twin Cities area, employee volunteer days at local hospitals, and a corporate giving program that matches employee donations. Surmodics also organizes internal hackathons and celebrates Medical Device Day to highlight employee achievements. In 2024, the company launched a virtual patient story series to connect employees with the impact of their work.

Employees and Workplace Culture

Surmodics fosters a culture of innovation, inclusivity, and wellness. Employees enjoy flexible work arrangements, comprehensive health benefits, and a 401(k) match. The company offers continuous learning through online training and tuition reimbursement. Diversity is tracked through employee resource groups for women in STEM and multicultural networks. The workplace environment is collaborative, with open-plan labs and break areas that encourage cross-functional interaction. Annual employee surveys show high satisfaction ratings (4.2/5 on Glassdoor). Surmodics also emphasizes mental health support, providing free counseling and mindfulness apps. The company’s low turnover rate (8%) reflects a strong sense of belonging and purpose among staff.

Job Details & Requirements for this Posting

Job Title: Senior Research Scientist, Drug Delivery Technologies

Location: Eden Prairie, MN (On-site)
Job Type: Full-time
Salary: $115,000 – $145,000 per year, plus performance bonus and equity

Responsibilities

• Lead research projects focused on novel drug-eluting coatings for balloon and stent applications
• Design experiments to characterize drug release kinetics, coating uniformity, and biocompatibility
• Collaborate with regulatory affairs to support FDA and CE Mark submissions
• Mentor junior scientists and interns
• Present findings at internal reviews and external scientific conferences
• Develop intellectual property through patent disclosures

Qualifications

• Ph.D. in Chemical Engineering, Materials Science, or related field with 5+ years industry experience
• Expertise in polymer chemistry, drug formulation, and controlled release mechanisms
• Hands-on experience with analytical techniques: HPLC, DSC, SEM, FTIR
• Proven track record of published research (minimum 5 peer-reviewed articles)
• Strong communication and project management skills
• Ability to work in a fast-paced, regulated environment

Why Join Surmodics Inc.

• Impact patient lives directly through life-saving technologies
• Work alongside world-class scientists and engineers
• Access to cutting-edge lab facilities and generous R&D budget
• Career growth pathway to Principal Scientist or R&D Manager
• Competitive compensation with profit-sharing and sabbatical program
• Inclusive culture that celebrates diverse perspectives

Customer Reviews and Industry Reputation

Surmodics has garnered strong reviews across multiple platforms, reflecting its reputation as a reliable partner and employer. Below is an exhaustive analysis based on employee and customer feedback.

Glassdoor

On Glassdoor, Surmodics holds a 4.1-star rating from over 150 reviews. Employees praise the collaborative culture, challenging work, and strong leadership. Common positives include “opportunities to innovate” and “supportive manager”. Some criticisms focus on bureaucracy in regulatory processes and occasional work-life balance challenges during product launch cycles. Overall, 85% of employees would recommend Surmodics to a friend.

Indeed

Indeed reviews average 4.0 stars. Employees highlight the company’s commitment to R&D and the high caliber of colleagues. One reviewer noted, “Best place I’ve worked for autonomy in research.” Negative feedback occasionally mentions slower promotion timelines compared to larger firms. Retention is aided by competitive salaries and a pleasant office environment.

Gartner Peer Insights

As a medical device supplier, Surmodics has limited direct Gartner reviews, but its diagnostic products receive positive feedback from clinical lab managers. One review stated, “SureWash assay kits improved our throughput by 20%.” The company is not a major IT player, so Gartner coverage is minimal.

Trustpilot

Trustpilot reviews from partner companies give Surmodics a 4.3 rating. Partners commend the technical support and responsiveness of the Surmodics team. A typical quote: “They helped us navigate FDA challenges with ease.” Criticisms relate to occasional lead times for custom coatings.

G2

G2 reviews are centered on Surmodics’ coating services. Users rate the quality of coatings at 4.5 stars, with particular praise for lubricity and durability. Some users mention that pricing is higher than generic alternatives, but value is seen as justified.

Google Reviews

Google reviews average 4.2 stars from employees and visitors. The corporate campus is described as modern and green. One visitor said, “Impressed by their cleanroom tours and knowledge.” Negative reviews are rare, mostly from disgruntled job applicants.

LinkedIn Reputation

On LinkedIn, Surmodics has a follower base of 25,000+. The company’s content strategy emphasizes thought leadership in coating technology. Employees frequently post about patent grants and conference presentations, boosting brand visibility. LinkedIn reviews (under company page) show a 4.3 rating, with comments on “great culture” and “innovative ambition.”

Why Organizations Choose Surmodics Inc.

Organizations choose Surmodics for its unmatched expertise in surface science, validated regulatory track record, and collaborative partnership model. Unlike generic coating providers, Surmodics offers bespoke R&D support and is willing to co-invest in regulatory studies. The company’s extensive patent portfolio provides a competitive edge, and its global supply chain ensures reliability. Moreover, Surmodics’ reputation for quality and innovation reduces risk for medical device firms seeking to bring new products to market quickly.

Official Contact Information

For inquiries and assistance, please reach out to Surmodics Inc. using the following contact details:

Address: 9924 West 74th Street, Eden Prairie, MN 55344, USA
Contact Number: +1 (952) 500-2000
Support Number: +1 (877) 786-7634
Helpdesk Number: +1 (952) 500-2999
Website: https://www.surmodics.com

Official Social Media Presence

• LinkedIn:linkedin.com/company/surmodics
• Twitter/X:@Surmodics
• Facebook:facebook.com/Surmodics
• YouTube:SurmodicsInc
• Instagram:@surmodics

SEO FAQ Section

Surmodics Inc. is known for developing advanced surface modification technologies and drug delivery systems for medical devices, including hydrophilic coatings and drug-coated balloons.

Surmodics Inc. is headquartered in Eden Prairie, Minnesota, USA.

Surmodics Inc. was founded in 1979.

Surmodics Inc. designs and manufactures coatings, drug delivery systems, and diagnostic reagents used by medical device and pharmaceutical companies.

Gary Maharaj is the CEO of Surmodics Inc. as of 2025.

Yes, Surmodics Inc. trades on NASDAQ under the ticker symbol SRDX.

Surmodics Inc. employs over 500 professionals globally.

Main products include the SurVeil™ drug-coated balloon, Serene® drug-coated balloon, SureWash™ diagnostic reagents, and custom coating services.

Yes, Surmodics Inc. provides R&D consulting, toll coating, and regulatory support through its partnership programs.

Surmodics Inc. serves cardiovascular, neurovascular, peripheral vascular, ophthalmology, and diagnostics markets.

Surmodics Inc. maintains ISO 13485 certification, follows FDA and CE Mark standards, and conducts rigorous testing.

Surmodics Inc. reported $120 million in revenue for fiscal year 2024.

Yes, Surmodics Inc. promotes diversity through employee resource groups and has 40% women in leadership roles.

Job openings at Surmodics Inc. are posted on its careers page and LinkedIn.

Surmodics Inc. fosters a culture of innovation, collaboration, and employee well-being with flexible work options.

Yes, Surmodics Inc. regularly exhibits at TCT, EuroPCR, and CRT meetings.

Surmodics Inc. holds over 900 issued and pending patents worldwide covering coating compositions and drug formulations.

Surmodics Inc. has set goals to reduce carbon footprint by 30% by 2027 and uses eco-friendly processes.

Yes, Surmodics Inc. offers regulatory consulting to help partners achieve FDA and international approvals.

Salaries at Surmodics Inc. range from $80,000 for entry-level to $150,000+ for senior research roles.

For additional corporate insights and industry resources, visit Surmodics Inc., the leader in medical surface innovation, and explore high-quality Paid Guest Posting Sites to amplify your brand's digital presence. Surmodics Inc.’s official website provides comprehensive details on its technologies, partnerships, and career opportunities. Meanwhile, leveraging guest post backlinks from reputable platforms can enhance the online visibility of healthcare organizations and medical device innovators seeking to share thought leadership content. By integrating such external resources, industry professionals can gain a fuller understanding of Surmodics Inc.’s ecosystem and the broader medtech landscape.